94 related articles for article (PubMed ID: 135641)
1. Inhibition of membrane transport of 5-fluoro[6-3H]deoxyuridine into L5178Y mouse leukemia cells.
Wigler PW; Schluter DN
Cancer Res; 1976 Sep; 36(9 pt.1):3207-11. PubMed ID: 135641
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of 5-fluoro-2'-deoxyuridine antineoplastic activity by 5-benzyloxybenzyloxybenzylacyclouridine in a human colon carcinoma cell line.
Chu E; Chu MY; Darnowski JW; Chen ZH; Pan BC; Chu SH
Cancer Res; 1992 Apr; 52(7):1729-36. PubMed ID: 1532344
[TBL] [Abstract][Full Text] [Related]
3. Defective transport of thymidine by cultured cells resistant to 5-bromodeoxyuridine.
Lynch TP; Cass CE; Paterson AR
J Supramol Struct; 1977; 6(3):363-74. PubMed ID: 145516
[TBL] [Abstract][Full Text] [Related]
4. Interaction of 2'-halogeno-2'-deoxyuridines with the human erythrocyte nucleoside transport mechanism.
Gati WP; Knaus EE; Wiebe LI
Mol Pharmacol; 1983 Jan; 23(1):146-52. PubMed ID: 6223203
[TBL] [Abstract][Full Text] [Related]
5. Thymidylate synthase is the principal target enzyme for the cytostatic activity of (E)-5-(2-bromovinyl)-2'-deoxyuridine against murine mammary carcinoma (FM3A) cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene.
Balzarini J; De Clercq E; Verbruggen A; Ayusawa D; Shimizu K; Seno T
Mol Pharmacol; 1987 Sep; 32(3):410-6. PubMed ID: 2823092
[TBL] [Abstract][Full Text] [Related]
6. Effects of 5-fluoro-2'-deoxyuridine on DNA metabolism in HeLa cells.
Cheng YC; Nakayama K
Mol Pharmacol; 1983 Jan; 23(1):171-4. PubMed ID: 6223204
[TBL] [Abstract][Full Text] [Related]
7. Effect of 5-fluoro-2'-deoxyuridine (FdUrd) on 5-bromo-2'-deoxyuridine (BrdUrd) incorporation into DNA measured with a monoclonal BrdUrd antibody and by the BrdUrd/Hoechst quenching effect.
Ellwart J; Dörmer P
Cytometry; 1985 Nov; 6(6):513-20. PubMed ID: 2415309
[TBL] [Abstract][Full Text] [Related]
8. Specificity of pyrimidine nucleoside phosphorylases and the phosphorolysis of 5-fluoro-2'-deoxyuridine.
Woodman PW; Sarrif AM; Heidelberger C
Cancer Res; 1980 Mar; 40(3):507-11. PubMed ID: 6451286
[TBL] [Abstract][Full Text] [Related]
9. 5-Fluoro-1-(2'-deoxy-2'-fluoro-beta-D-ribofuranosyl) uracil trapping in Morris hepatoma cells expressing the herpes simplex virus thymidine kinase gene.
Germann C; Shields AF; Grierson JR; Morr I; Haberkorn U
J Nucl Med; 1998 Aug; 39(8):1418-23. PubMed ID: 9708520
[TBL] [Abstract][Full Text] [Related]
10. Rapid determination of thymidylate synthase activity and its inhibition in intact L1210 leukemia cells in vitro.
Yalowich JC; Kalman TI
Biochem Pharmacol; 1985 Jul; 34(13):2319-24. PubMed ID: 3160352
[TBL] [Abstract][Full Text] [Related]
11. Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels.
Grem JL; Fischer PH
Cancer Res; 1986 Dec; 46(12 Pt 1):6191-9. PubMed ID: 2946402
[TBL] [Abstract][Full Text] [Related]
12. Interactions of nucleoside analogs, caffeine, and nicotine with human concentrative nucleoside transporters 1 and 2 stably produced in a transport-defective human cell line.
Lang TT; Young JD; Cass CE
Mol Pharmacol; 2004 Apr; 65(4):925-33. PubMed ID: 15044622
[TBL] [Abstract][Full Text] [Related]
13. Thymidine kinase as a determinant of the response to 5-fluoro-2'-deoxyuridine in transplantable murine leukemias.
Kessel D; Wodinsky I
Mol Pharmacol; 1970 May; 6(3):251-4. PubMed ID: 5443530
[No Abstract] [Full Text] [Related]
14. Prevention of methotrexate cytotoxicity by asparaginase inhibition of methotrexate polyglutamate formation.
Jolivet J; Cole DE; Holcenberg JS; Poplack DG
Cancer Res; 1985 Jan; 45(1):217-20. PubMed ID: 2578094
[TBL] [Abstract][Full Text] [Related]
15. Variability of 5-bromo-2'-deoxyuridine incorporation into DNA of human glioma cell lines and modulation with fluoropyrimidines.
Mancini WR; Stetson PL; Lawrence TS; Wagner JG; Greenberg HS; Ensminger WD
Cancer Res; 1991 Feb; 51(3):870-4. PubMed ID: 1824826
[TBL] [Abstract][Full Text] [Related]
16. Comparison of BrdUrd and [3H]TdR incorporation to estimate cell proliferation, cell loss, and potential doubling time in tumor xenografts.
Zätterström UK; Johansson M; Källén A; Baldetorp B; Oredsson S; Wennerberg J; Killander D
Cytometry; 1992; 13(8):872-9. PubMed ID: 1459003
[TBL] [Abstract][Full Text] [Related]
17. [Effect of hematoporphyrin derivative (HpD) on nucleoside transport and nucleoside kinase activity of cancer cells].
Fu NW
Zhonghua Zhong Liu Za Zhi; 1986 Jan; 8(1):35-8. PubMed ID: 2942381
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of nucleoside transport in murine lymphoma L5178Y cells and human erythrocytes by the uridine phosphorylase inhibitors 5-benzylacyclouridine and 5-benzyloxybenzylacyclouridine.
Lee KH; el Kouni MH; Chu HS; Cha S
Cancer Res; 1984 Sep; 44(9):3744-8. PubMed ID: 6744292
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of uptake of nitrosoureas by L5178Y lymphoblasts in vitro.
Begleiter A; Lam HP; Goldenberg GJ
Cancer Res; 1977 Apr; 37(4):1022-7. PubMed ID: 557367
[TBL] [Abstract][Full Text] [Related]
20. Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331: a water-soluble, nonpolyglutamatable, quinazoline-based inhibitor of thymidylate synthase.
Jackman AL; Kimbell R; Aherne GW; Brunton L; Jansen G; Stephens TC; Smith MN; Wardleworth JM; Boyle FT
Clin Cancer Res; 1997 Jun; 3(6):911-21. PubMed ID: 9815766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
